Paper1102002
Principles of combination therapy.
Levin S and 1 other. Bull N Y Acad Med, 1975. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Principles of combination therapy. Papers, record 1102002. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1102002
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Infective Agents | Major topic |
| Bacterial Infections | Major topic |
| Drug Therapy, Combination | Major topic |
| Anti-Bacterial Agents | |
| Dose-Response Relationship, Drug | |
| Drug Antagonism | |
| Drug Synergism | |
| Endocarditis, Bacterial | |
| Humans | |
| Pseudomonas Infections | |
| Sulfamethoxazole | |
| Trimethoprim |
Source PubMed
References89
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4180218 | Resistance of Pseudomonas aeruginosa to carbenicillin. | Lancet | 1969 | https://conductscience.org/library/papers/4180218 | PubMed |
| 2 | 4188384 | Fusidic acid and lincomycin therapy in staphylococcal infections in cystic fibrosis. | Lancet | 1970 | https://conductscience.org/library/papers/4188384 | PubMed |
| 3 | 4374476 | Modification of human neutrophil response to endotoxin with polymyxin B sulfate. | J Infect Dis | 1974 | https://conductscience.org/library/papers/4374476 | PubMed |
| 4 | 4382581 | Studies on the pathogenesis of meningitis. VI. Antagonism between penicillin and chloramphenicol in experimental pneumococcal meningitis. | J Lab Clin Med | 1967 | https://conductscience.org/library/papers/4382581 | PubMed |
| 5 | 4357095 | Pseudomonas cepacia tricuspid endocarditis: treatment with trimethoprim, sulfonamide, and polymyxin B. | J Infect Dis | 1973 | https://conductscience.org/library/papers/4357095 | PubMed |
| 6 | 4316000 | The synergistic action of the sulfonamides and the polymyxins against Serratia marcescens. | J Infect Dis | 1970 | https://conductscience.org/library/papers/4316000 | PubMed |
| 7 | 4306976 | Gram-negative rod bacteremia. | J Infect Dis | 1969 | https://conductscience.org/library/papers/4306976 | PubMed |
| 8 | 4579141 | In vivo antagonism between gentamicin and chloramphenicol in neutropenic mice. | J Infect Dis | 1973 | https://conductscience.org/library/papers/4579141 | PubMed |
| 9 | 4596743 | Clinical significance of in vitro synergism between antibiotics in gram-negative infections. | Antimicrob Agents Chemother | 1972 | https://conductscience.org/library/papers/4596743 | PubMed |
| 10 | 4599860 | Synergistic action of ampicillin and erythromycin against Nocardia asteroides: effect of time of incubation. | Antimicrob Agents Chemother | 1974 | https://conductscience.org/library/papers/4599860 | PubMed |
| 11 | 4550233 | Interactions among antibiotics and other drugs. | JAMA | 1972 | https://conductscience.org/library/papers/4550233 | PubMed |
| 12 | 4491548 | Interactions between fusidic acid and penicillins. | J Med Microbiol | 1973 | https://conductscience.org/library/papers/4491548 | PubMed |
| 13 | 4490252 | Antibiotic synergism against group D streptococci in the treatment of endocarditis. | Med J Aust | 1973 | https://conductscience.org/library/papers/4490252 | PubMed |
| 14 | 4489479 | Comparison of treatments with several antibiotics in experimental infections due to methicillin-resistant Staphylococcus aureus. | J Infect Dis | 1972 | https://conductscience.org/library/papers/4489479 | PubMed |
| 15 | 4462463 | Combined amphotericin B-tetracycline therapy for experimental coccidioidomycosis. | Antimicrob Agents Chemother | 1974 | https://conductscience.org/library/papers/4462463 | PubMed |
| 16 | 4816171 | Chronic mucocutaneous candidiasis: immunologic and antibiotic therapy. | Ann Intern Med | 1974 | https://conductscience.org/library/papers/4816171 | PubMed |
| 17 | 4791489 | Successful treatment of Pseudomonas cepacia endocarditis with trimethoprim-sulfamethoxazole. | Antimicrob Agents Chemother | 1973 | https://conductscience.org/library/papers/4791489 | PubMed |
| 18 | 4823583 | Penicillin-aminoglycoside synergy in experimental Streptococcus viridans endocarditis. | J Infect Dis | 1974 | https://conductscience.org/library/papers/4823583 | PubMed |
| 19 | 4758830 | Bactericidal effect of combinations of nalidixic acid and various antibiotics on Enterobacteriaceae. | Antimicrob Agents Chemother | 1973 | https://conductscience.org/library/papers/4758830 | PubMed |
| 20 | 4758061 | Trimethoprim-sulfamethoxazole. Summary and comments on the conference. | J Infect Dis | 1973 | https://conductscience.org/library/papers/4758061 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39345262 | Current and emerging approaches for eliminating Borrelia burgdorferi and alleviating persistent Lyme disease symptoms. | Front Microbiol | 2024 | https://conductscience.org/library/papers/39345262 | PubMed |
| 37899968 | A mechanistic assessment of the nature of pharmacodynamic drug-drug interaction in vivo and in vitro. | In Silico Pharmacol | 2023 | https://conductscience.org/library/papers/37899968 | PubMed |
| 37138535 | Potential clinical value of catheters impregnated with antimicrobials for the prevention of infections associated with peritoneal dialysis. | Expert Rev Med Devices | 2023 | https://conductscience.org/library/papers/37138535 | PubMed |
| 32123189 | Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31. | Sci Rep | 2020 | https://conductscience.org/library/papers/32123189 | PubMed |
| 30816136 | Comparison of null models for combination drug therapy reveals Hand model as biochemically most plausible. | Sci Rep | 2019 | https://conductscience.org/library/papers/30816136 | PubMed |
| 26014929 | Borrelia burgdorferi, the Causative Agent of Lyme Disease, Forms Drug-Tolerant Persister Cells. | Antimicrob Agents Chemother | 2015 | https://conductscience.org/library/papers/26014929 | PubMed |
| 25121020 | Burden of antibiotic resistance in common infectious diseases: role of antibiotic combination therapy. | J Clin Diagn Res | 2014 | https://conductscience.org/library/papers/25121020 | PubMed |
| 16033288 | Antifungal combination therapy: clinical potential. | Drugs | 2005 | https://conductscience.org/library/papers/16033288 | PubMed |
| 879749 | In vitro synergism between carbenicillin and aminoglycosidic aminocyclitols against Acinetobacter calcoaceticus var. anitratus. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/879749 | PubMed |
| 646344 | Quantitation of antibiotics by high-pressure liquid chromatography: cephalothin. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/646344 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1102002
GET https://conductscience.org/api/papers/v1/1102002/references?page=2